NRX Pharmaceuticals (NRXP) EBT Growth (1y) (2019 - 2026)
NRX Pharmaceuticals (NRXP) EBT Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.10% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,140.26% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 71.54% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.15% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.57% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | NRX Pharmaceuticals | 137.57 Mn | 130.87 Mn | 437,000.00 | -29.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.33% |
| Dec 31, 2025 | -90.28% |
| Sep 30, 2025 | -39.62% |
| Jun 30, 2025 | 47.07% |
| Mar 31, 2025 | 39.43% |
| Dec 31, 2024 | 44.97% |
| Sep 30, 2024 | 51.27% |
| Jun 30, 2024 | 12.93% |
| Mar 31, 2024 | -59.94% |
| Dec 31, 2023 | 64.15% |
| Sep 30, 2023 | 33.62% |
| Jun 30, 2023 | 17.04% |
| Mar 31, 2023 | 76.26% |
| Dec 31, 2022 | 59.53% |
| Sep 30, 2022 | 74.83% |
| Jun 30, 2022 | -8,190.75% |
| Mar 31, 2022 | -1,769.83% |
| Dec 31, 2021 | 32.62% |
| Sep 30, 2021 | -617.77% |
| Jun 30, 2021 | -214.98% |